Clinical trial · Interventional
Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemotherapy for Breast Cancer and in Healthy Participants
Efficacy of Topical Bimatoprost in Promoting Hair Growth in the Region of the Eyebrow and Eyelashes for Post-chemotherapy Patients Versus Normal Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Study was never opened
Summary
Brief summary (as posted)
RATIONALE: Bimatoprost ophthalmic solution may help increase eyebrow and eyelash growth in patients who have undergone chemotherapy. PURPOSE: This randomized clinical trial is studying how wells bimatoprost ophthalmic solution works in increasing eyebrow and eyelash growth in patients who have undergone chemotherapy for breast cancer and in healthy participants.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Alopecia | — | UNRESOLVED | — |
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| bimatoprost ophthalmic solution | Drug | — | UNRESOLVED |
| placebo | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Arm I
- description
- Patients apply topical bimatoprost ophthalmic solution to base of upper eyelid margins OR to eyebrow region once daily for 4 months in the absence of unacceptable toxicity.
- interventionNames
- Drug: bimatoprost ophthalmic solution
- type
- PLACEBO_COMPARATOR
- label
- Arm II
- description
- Patients apply topical placebo solution to base of upper eyelid margins OR to eyebrow region once daily for 4 months in the absence of unacceptable toxicity.
- interventionNames
- Drug: placebo
Primary outcomes (1)
- measure
- Measuring regrowth of eyebrows and eyelashes by Bimatoprost Opthalmic solution
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Meets 1 of the following criteria: * Diagnosis of breast cancer (group 1) * Completed chemotherapy within the past month that has resulted in eyebrow alopecia or eyelash hypotrichosis * Eyebrow score of 0-2 or eyelash score of 0-2 on the study's qualitative eyebrow or eyelash growth chart * Has no known underlying disease (group 2) * Desires thicker, fuller, or more numerous eyebrows Exclusion criteria * pregnant * does not Speak a language adequately covered by study translator services * cognitive impairment * history of trauma or burn to the eyebrow region, alopecia areata, or trichotillomania * known diagnoses possibly underlying or contributing to the state of the eyebrows including, but not limited to, telogen effluvium or anagen effluvium (group 2) * active ocular disease (group 1) * thyroid hormone level abnormalities (group 2) * More than 2 years since prior ocular surgery (group 1) * prior topical medication for increasing eyebrow growth within 30 days od starting study treatment * concomitant chemotherapy for the treatment of cancer (group 1) * concomitant therapy for eyelash or eyebrow growth
References
Publications (0)
Data not yet available